Eastgate Biotech Corp Stock Current Liabilities
ETBIDelisted Stock | USD 0 0.00 0.00% |
Eastgate Biotech Corp fundamentals help investors to digest information that contributes to Eastgate Biotech's financial success or failures. It also enables traders to predict the movement of Eastgate Stock. The fundamental analysis module provides a way to measure Eastgate Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Eastgate Biotech stock.
Eastgate |
Eastgate Biotech Corp Company Current Liabilities Analysis
Eastgate Biotech's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current Eastgate Biotech Current Liabilities | 2.11 M |
Most of Eastgate Biotech's fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Eastgate Biotech Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
CompetitionIn accordance with the recently published financial statements, Eastgate Biotech Corp has a Current Liabilities of 2.11 M. This is 99.88% lower than that of the Healthcare sector and significantly higher than that of the Pharmaceuticals industry. The current liabilities for all United States stocks is 99.97% higher than that of the company.
Did you try this?
Run Price Ceiling Movement Now
Price Ceiling MovementCalculate and plot Price Ceiling Movement for different equity instruments |
All Next | Launch Module |
Eastgate Fundamentals
Operating Margin | (74.40) % | |||
Current Valuation | 18.92 M | |||
Shares Outstanding | 2.06 B | |||
Price To Earning | (0.10) X | |||
Price To Sales | 1.49 X | |||
EBITDA | (3.55 M) | |||
Net Income | (2.98 M) | |||
Cash And Equivalents | 4.91 K | |||
Total Debt | 1.67 M | |||
Current Ratio | 0.02 X | |||
Book Value Per Share | (0) X | |||
Cash Flow From Operations | (389.48 K) | |||
Earnings Per Share | (0.01) X | |||
Beta | -3039.35 | |||
Market Capitalization | 205.75 K | |||
Retained Earnings | (14.63 M) | |||
Working Capital | (1.94 M) | |||
Current Asset | 167 K | |||
Current Liabilities | 2.11 M |
About Eastgate Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Eastgate Biotech Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Eastgate Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Eastgate Biotech Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Consideration for investing in Eastgate Stock
If you are still planning to invest in Eastgate Biotech Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eastgate Biotech's history and understand the potential risks before investing.
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |